Skip to main content
Log in

Objective assessment of nonadherence and unknown co-medication in hospitalized patients

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The intake of medications (drugs) without the knowledge of the treating physician (unknown co-medication) and nonadherence strongly influence drug safety. The aim of our study was to objectively assess unknown co-medication and nonadherence in hospitalized patients by screening urine for a large number of drugs using highly sensitive full scan gas chromatograpy/mass spectrometry (GC/MS). Secondary objectives were to determine the relationship of co-medication and nonadherence to the number of drugs prescribed and to compare history-taking by a pharmacist versus a physician.

Methods

In 152 patients, the drug histories taken by physicians, patients’ self-reported adherence, and information compiled during as many as three structured interviews conducted by a trained pharmacist on days 1–2, 3–4, and 7–11 of the hospital stay were compared with the GC/MS results from urine samples collected after each interview.

Results

In the interviews performed by the pharmacist, 235 additional drugs were identified that were not documented in the chart. Of all the drugs indicated in any interview, 16.9% were identified only by the physician, 24.1% only by the pharmacist, and 59% by both. Overall, in 78% of the patients at least one additional drug was identified by urine screening. The findings suggest overall nonadherence to at least one drug in 13.0% of patients on admission and in 23.3% of patients at any time during hospitalization. Nonadherence was less frequent for critical dose drugs and correlated with the number of prescribed drugs.

Conclusions

The drug history among hospitalized patients is often incomplete, and nonadherence and unknown co-medication are alarmingly frequent. This lack of knowledge might impact the overall success of drug therapies in the hospital setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Seidling HM, Schmitt SPW, Bruckner T, Kaltschmidt J, Pruszydlo M, Senger C, Bertsche T, Walter-Sack I, Haefeli WE (2010) Patient-specific electronic decision support reduces prescription of excessive doses. Qual Saf Health Care 19:e15

    Article  PubMed  CAS  Google Scholar 

  2. Bertsche T, Bertsche A, Krieg E-M, Kunz N, Bergmann K, Hanke G, Hoppe-Tichy T, Ebinger F, Haefeli WE (2010) Prospective pilot intervention study to prevent medication errors in drugs administered to children by mouth or gastric tube: a program for nurses, physicians and parents. Qual Saf Health Care 19:e26

    Article  Google Scholar 

  3. Carter MK, Allin DM, Scott LA, Grauer D (2006) Pharmacist-acquired medication histories in a university hospital emergency department. Am J Health Syst Pharm 63:2500–2503

    Article  PubMed  Google Scholar 

  4. Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE (2005) Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. Can Med Assoc J 30(173):510–515

    Article  Google Scholar 

  5. Frank C, Godwin M, Verma S, Kelly A, Birenbaum A, Seguin R, Anderson J (2001) What drugs are our frail elderly patients taking? Do drugs they take or fail to take put them at increased risk of interactions and inappropriate medication use? Can Fam Phys 47:1198–1204

    CAS  Google Scholar 

  6. Bergman U, Wiholm BE (1981) Patient medication on admission to a medical clinic. Eur J Clin Pharmacol 20:185–191

    Article  PubMed  CAS  Google Scholar 

  7. Karkov LL, Schytte-Hansen S, Haugbolle LS (2010) Discrepancies between sources providing the medication histories of acutely hospitalised patients. Pharm World Sci 32:449–454

    Article  PubMed  Google Scholar 

  8. Jones HA, Metz JM, Devine P, Hahn SM, Whittington R (2002) Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions. Urology 59:272–276

    Article  PubMed  Google Scholar 

  9. Akwagyriam I, Goodyer LI, Harding L, Khakoo S, Millington H (1996) Drug history taking and the identification of drug related problems in an accident and emergency department. J Accid Emerg Med 13:166–168

    Article  PubMed  CAS  Google Scholar 

  10. Lau HS, Florax C, Porsius AJ, De Boer A (2000) The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 49:597–603

    Article  PubMed  CAS  Google Scholar 

  11. Rieger K, Scholer A, Arnet I, Peters FT, Maurer HH, Walter-Sack I, Haefeli WE, Martin-Facklam M (2004) High prevalence of unknown co-medication in hospitalised patients. Eur J Clin Pharmacol 60:363–368

    Article  PubMed  Google Scholar 

  12. Schwab M, Roder F, Ammon S, Thon KP, Mörike K (1999) Increased number of hip fractures. Lancet 353:2160

    Article  PubMed  CAS  Google Scholar 

  13. Martin-Facklam M, Rieger K, Riedel K-D, Burhenne J, Walter-Sack I, Haefeli WE (2004) Undeclared exposure to St. John’s Wort in hospitalized patients. Br J Clin Pharmacol 58:437–441

    Article  PubMed  CAS  Google Scholar 

  14. Berndt S, Maier C, Schütz HW (1993) Polymedication and medication compliance in patients with chronic non-malignant pain. Pain 52:331–339

    Article  PubMed  CAS  Google Scholar 

  15. Peters FT, Drvarov O, Lottner S, Spellmeier A, Rieger K, Haefeli WE, Maurer HH (2009) A systematic comparison of four different workup procedures for systematic toxicological analysis of urine samples using gas chromatography-mass spectrometry. Anal Bioanal Chem 393:735–745

    Article  PubMed  CAS  Google Scholar 

  16. Maurer HH, Pfleger K, Weber AA (2011) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim

    Google Scholar 

  17. Spitzer WO (1991) Drugs as determinants of health and disease in the population. An orientation to the bridge science of pharmacoepidemiology. J Clin Epidemiol 44:823–830

    Article  PubMed  CAS  Google Scholar 

  18. Health Canada (2006) Guidance for industry: Bioequivalence requirements: critical dose drugs. Available at: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/bio/critical_dose_critique-eng.php. Accessed 31 Oct 2011

  19. Seidling HM, Al Barmawi A, Kaltschmidt J, Bertsche T, Pruszydlo MG, Haefeli WE (2007) Detection and prevention of prescriptions with excessive doses in electronic prescribing systems. Eur J Clin Pharmacol 63:1185–1192

    Article  PubMed  CAS  Google Scholar 

  20. Laufs U, Rettig-Ewen V, Böhm M (2011) Strategies to improve drug adherence. Eur Heart J 32:264–268

    Article  PubMed  Google Scholar 

  21. Kaiser RM, Schmader KE, Pieper CF, Lindblad CI, Ruby CM, Hanlon JT (2006) Therapeutic failure-related hospitalisations in the frail elderly. Drugs Aging 23:579–586

    Article  PubMed  Google Scholar 

  22. Chan M, Nicklason F, Vial JH (2001) Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 31:199–205

    Article  PubMed  CAS  Google Scholar 

  23. Col N, Fanale JE, Kronholm P (1990) The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150:841–845

    Article  PubMed  CAS  Google Scholar 

  24. Schmassmann-Suhijar D, Bullingham R, Gasser R, Schmutz J, Haefeli WE (1998) Rhabdomyolysis due to interaction of simvastatin with mibefradil. Lancet 351:1929–1930

    Article  PubMed  CAS  Google Scholar 

  25. Lapierre G, Leonard P (1980) L’histoire medicamenteuse acquise par le pharmacien. Can J Hosp Pharm 1:12–15

    Google Scholar 

  26. Detry JM, Block P, De Backer G, Degaute JP (1995) Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. The Belgian Collaborative Study Group. Eur J Clin Pharmacol 47:477–481

    Article  PubMed  CAS  Google Scholar 

  27. Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23:1296–1310

    Article  PubMed  CAS  Google Scholar 

  28. Stewart RB, Cluff LE (1972) A review of medication errors and compliance in ambulant patients. Clin Pharmacol Ther 13:463–468

    PubMed  CAS  Google Scholar 

  29. Krueger KP, Berger BA, Felkley B (2005) Medication adherence and persistence: a comprehensive review. Adv Ther 22:319–362

    Article  Google Scholar 

  30. Ziessler M, Mehlhorn J, Zimmermann S (1990) Drug taking behavior of internal medicine inpatients. Z Ges Inn Med 45:158–161

    PubMed  CAS  Google Scholar 

  31. Johnell K, Klarin I (2007) The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 30:911–918

    Article  PubMed  Google Scholar 

  32. Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ (1989) The human debrisoquine 4-hydroxylase (CYP2D) Locus: sequence and identification of the polymorphic CYP2D6 gene, al related gene, and a pseudogene. Am J Hum Genet 45:889–904

    PubMed  CAS  Google Scholar 

  33. Johansson I, Lundquist E, Bertilsson L, Dahl MJ, Sjöquist F, Ingelmann-Sundberg M (1993) Inherited amplification of an active gene in he cytochrome P450 CYP2D6 locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci USA 90:11825–11829

    Article  PubMed  CAS  Google Scholar 

  34. Warne S, Endacott R, Ryan H, Chamberlain W, Hendry J, Boulanger C, Donlin N (2010) Non-therapeutic omission of medications in acutely ill patients. Nurs Crit Care 15:112–117

    Article  PubMed  Google Scholar 

  35. Bertsche T, Niemann D, Mayer Y, Ingram K, Hoppe-Tichy T, Haefeli WE (2008) Prioritising the prevention of medication handling errors. Pharm World Sci 30:907–915

    Article  PubMed  Google Scholar 

  36. Blacklock CJ, Lawrence JR, Wiles D, Malcolm EA, Gibson IH, Kelly CJ, Paterson JR (2001) Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J Clin Pathol 54:553–555

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Walter E. Haefeli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carow, F., Rieger, K., Walter-Sack, I. et al. Objective assessment of nonadherence and unknown co-medication in hospitalized patients. Eur J Clin Pharmacol 68, 1191–1199 (2012). https://doi.org/10.1007/s00228-012-1229-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-012-1229-2

Keywords

Navigation